WPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
WPHARMA
Largest movements
- Cash -€19,642
down €19,642 (-46.2%), from €42,532 to €22,890
mainly Debts after one year (-€31,383) and Current portion of long-term debt (-€17,648)
- Receivables within one year +€11,988
up €11,988 (+1,933%), from €620 to €12,608
of which Trade receivables: +€12,608
- Reserves +€47,204
up €47,204 (+20.0%), from €236,598 to €283,801
of which Distributable reserves: +€52,204
- Debts after one year -€31,383
down €31,383 (-19.2%), from €163,117 to €131,733
- Current portion of long-term debt -€17,648
down €17,648 (-25.6%), from €69,031 to €51,383
- Other debts -€12,962
down €12,962 (-15.4%), from €83,940 to €70,978
- Gross operating margin +€14,510
up €14,510 (+21.9%), from €66,190 to €80,700
- Taxes +€4,979
up €4,979 (+37.0%), from €13,473 to €18,451
- Financial charges -€3,485
down €3,485 (-19.1%), from €18,200 to €14,716
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €971,101 | €960,747 | -€10,354 | -1.1% |
| Fixed assets | 21/28 | €925,000 | €925,000 | = | 0.0% |
| Financial fixed assets | 28 | €925,000 | €925,000 | = | 0.0% |
| Current assets | 29/58 | €46,101 | €35,747 | -€10,354 | -22.5% |
| Amounts receivable within one year | 40/41 | €620 | €12,608 | +€11,988 | +1,933% |
| Trade receivables | 40 | - | €12,608 | +€12,608 | |
| Other amounts receivable | 41 | €620 | - | -€620 | |
| Cash at bank and in hand | 54/58 | €42,532 | €22,890 | -€19,642 | -46.2% |
| Deferred charges and accrued income | 490/1 | €2,949 | €249 | -€2,700 | -91.6% |
| Total equity and liabilities | 10/49 | €971,101 | €960,747 | -€10,354 | -1.1% |
| Equity | 10/15 | €641,055 | €688,259 | +€47,204 | +7.4% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €236,598 | €283,801 | +€47,204 | +20.0% |
| Non-distributable reserves | 130/1 | €5,000 | - | -€5,000 | |
| Reserves not available under the articles | 1311 | €5,000 | - | -€5,000 | |
| Distributable reserves | 133 | €231,598 | €283,801 | +€52,204 | +22.5% |
| Profit (loss) carried forward | 14 | €354,458 | €354,458 | = | 0.0% |
| Amounts payable | 17/49 | €330,046 | €272,488 | -€57,558 | -17.4% |
| Amounts payable after more than one year | 17 | €163,117 | €131,733 | -€31,383 | -19.2% |
| Financial debts | 170/4 | €163,117 | €131,733 | -€31,383 | -19.2% |
| Amounts payable within one year | 42/48 | €163,029 | €136,854 | -€26,174 | -16.1% |
| Current portion of amounts payable after more than one year | 42 | €69,031 | €51,383 | -€17,648 | -25.6% |
| Trade debts | 44 | - | €150 | +€150 | |
| Suppliers | 440/4 | - | €150 | +€150 | |
| Taxes, remuneration and social security | 45 | €10,057 | €14,343 | +€4,285 | +42.6% |
| Taxes | 450/3 | €10,057 | €14,343 | +€4,285 | +42.6% |
| Other amounts payable | 47/48 | €83,940 | €70,978 | -€12,962 | -15.4% |
| Accrued charges and deferred income | 492/3 | €3,900 | €3,900 | = | 0.0% |
| Other operating charges | 640/8 | €266 | €329 | +€63 | +23.6% |
| Gross operating margin | 9900 | €66,190 | €80,700 | +€14,510 | +21.9% |
| Operating profit (loss) | 9901 | €65,924 | €80,371 | +€14,447 | +21.9% |
| Financial charges | 65/66B | €18,200 | €14,716 | -€3,485 | -19.1% |
| Recurring financial charges | 65 | €18,200 | €14,716 | -€3,485 | -19.1% |
| Profit (loss) for the period before taxes | 9903 | €47,723 | €65,655 | +€17,932 | +37.6% |
| Income taxes | 67/77 | €13,473 | €18,451 | +€4,979 | +37.0% |
| Profit (loss) for the period | 9904 | €34,251 | €47,204 | +€12,953 | +37.8% |
| Profit (loss) for the period to be appropriated | 9905 | €34,251 | €47,204 | +€12,953 | +37.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.